1. Home
  2. PLYX vs BNED Comparison

PLYX vs BNED Comparison

Compare PLYX & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$6.27

Market Cap

271.8M

Sector

Health Care

ML Signal

N/A

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$10.15

Market Cap

284.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLYX
BNED
Founded
2014
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
271.8M
284.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PLYX
BNED
Price
$6.27
$10.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
521.3K
186.7K
Earning Date
05-14-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.39
Revenue
N/A
$1,610,170,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$25.72
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$5.90
52 Week High
$9.18
$12.19

Technical Indicators

Market Signals
Indicator
PLYX
BNED
Relative Strength Index (RSI) 52.73 70.76
Support Level $2.37 $8.22
Resistance Level $7.43 $11.94
Average True Range (ATR) 1.17 0.43
MACD -0.13 0.10
Stochastic Oscillator 31.91 90.32

Price Performance

Historical Comparison
PLYX
BNED

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

Share on Social Networks: